Protocol Ledger

Biopharma Industry · Consolidated Sponsor Hub

ModernaTX: Clinical Trials & FDA Approval Profile

ModernaTX (Global / Institutional) sponsors 62 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 14 active protocols (7 recruiting now), 42 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)9.7%
Median Closed Enrollment vs National (145 pts)879 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for ModernaTX
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)62
Active Pipeline (Recruiting Now)14 (7)
Completed vs Stopped Early42 / 6 (9.7%)
Median Closed Actual Enrollment879 participants
Physical Hospital Site Disclosure99.9% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With ModernaTX
Hospital Research SiteLocationShared Protocols
Velocity Clinical Research (Meridian)Meridian, ID13
Velocity Clinical Research (Cincinnati)Cincinnati, OH11

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by ModernaTX
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT07496450A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy AdultsPhase IIIACTIVE NOT RECRUITING
NCT06067230A Study to Investigate the Immunogenicity and Safety of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in High-risk AdultsPhase IIICOMPLETED
NCT05249829A Study to Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19Phase II/IIICOMPLETED
NCT05415462A Study of mRNA-1010 Seasonal Influenza Vaccine in AdultsPhase IIICOMPLETED

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Moderna across sibling Meru public-data platforms.

Explore interactive annual charts and M&A subsidiary rollups in the ModernaTX Interactive Dossier, benchmark peers in Infectious Disease and Vaccines, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI